Strides Pharma Science has informed about submission of the Unaudited Financial Results (Standalone and Consolidated) of the Company along with Limited Review Report of the Statutory Auditors for the quarter and nine months ended December 31, 2019, as approved by the Board of Directors of the Company at their meeting held today, along with a press release issued in this regard. The board meeting commenced at 08:00 hrs and concluded at 09:00 hrs.
The above information is a part of company’s filings submitted to BSE.
